[
    [
        {
            "time": "2021-03-26",
            "original_text": "西南证券维持贝达药业持有评级：业绩维持高速增长，公司逐渐进入收获期",
            "features": {
                "keywords": [
                    "贝达药业",
                    "持有评级",
                    "业绩增长",
                    "收获期"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "西南证券维持贝达药业持有评级：业绩维持高速增长，公司逐渐进入收获期",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "贝达药业(300558)：2020完美收官 2021值得期待 从1到多新征程开启",
            "features": {
                "keywords": [
                    "贝达药业",
                    "2020年",
                    "完美收官",
                    "2021年",
                    "新征程"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "贝达药业(300558)：2020完美收官 2021值得期待 从1到多新征程开启",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "国盛证券维持贝达药业买入评级：2020完美收官，2021值得期待，从1到多新征程开启",
            "features": {
                "keywords": [
                    "贝达药业",
                    "买入评级",
                    "2020年",
                    "完美收官",
                    "2021年",
                    "新征程"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国盛证券维持贝达药业买入评级：2020完美收官，2021值得期待，从1到多新征程开启",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "每日“药”闻|蓝帆医疗商誉减值17.6亿；多家药企公布业绩，先声药业利润下滑34%",
            "features": {
                "keywords": [
                    "蓝帆医疗",
                    "商誉减值",
                    "药企",
                    "业绩",
                    "先声药业",
                    "利润下滑"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "每日“药”闻|蓝帆医疗商誉减值17.6亿；多家药企公布业绩，先声药业利润下滑34%",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "国金证券-贝达药业:埃克替尼放量，恩沙替尼接棒，多药上市中【公司研究】",
            "features": {
                "keywords": [
                    "贝达药业",
                    "埃克替尼",
                    "恩沙替尼",
                    "多药上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国金证券-贝达药业:埃克替尼放量，恩沙替尼接棒，多药上市中【公司研究】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "上市公司正负面新闻2021年3月26日星期五",
            "features": {
                "keywords": [
                    "上市公司",
                    "正负面新闻"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上市公司正负面新闻2021年3月26日星期五",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 2,
                "Duration": 3,
                "Entity_Density": 1,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "2021-03-26",
            "original_text": "贝达药业：2020年盈利6.06亿元，同比增长162.79%",
            "features": {
                "keywords": [
                    "贝达药业",
                    "2020年",
                    "盈利",
                    "同比增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业：2020年盈利6.06亿元，同比增长162.79%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]